XFOR Stock Summary and Trading Ideas (X4 Pharmaceuticals | NASDAQ:XFOR)

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

X4 Pharmaceuticals trades on the NASDAQ stock market under the symbol XFOR.

As of April 30, 2026, XFOR stock price declined to $4.07 with 271,426 million shares trading.

XFOR has a beta of -0.08, meaning it tends to be less sensitive to market movements. XFOR has a correlation of 0.00 to the broad based SPY ETF.

XFOR has a market cap of $370.04 million. This is considered a Small Cap stock.

Last quarter X4 Pharmaceuticals reported $3 million in Revenue and -$.22 earnings per share. This beat revenue expectation by $856,200 and exceeded earnings estimates by $.13.

In the last 3 years, XFOR traded as high as $77.25 and as low as $1.35.

The top ETF exchange traded funds that XFOR belongs to (by Net Assets): VTI, VXF, PRFZ, AVSC, ITWO.

XFOR has underperformed the market in the last year with a price return of -6.4% while the SPY ETF gained +31.0%. However, in the short term, XFOR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +10.3% vs +3.8% return in SPY. But in the last 2 weeks, XFOR shares have been beat by the market, returning -6.0% compared to an SPY return of +2.7%.

XFOR support price is $3.94 and resistance is $4.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XFOR shares will trade within this expected range on the day.